|
1
|
El Serag HB: Hepatocellular carcinoma. N
Engl J Med. 365:1118–1127. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pang RW, Joh JW, Johnson PJ, Monden M,
Pawlik TM and Poon RT: Biology of hepatocellular carcinoma. Ann
Surg Oncol. 15:962–971. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
El Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Altekruse SF, McGlynn KA and Reichman ME:
Hepatocellular carcinoma incidence, mortality, and survival trends
in the United States from 1975 to 2005. J Clin Oncol. 27:1485–1491.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hagymási K and Tulassay Z: Epidemiology,
risk factors and molecular pathogenesis of primary liver cancer.
Orv Hetil. 149:541–548. 2008.In Hungarian. View Article : Google Scholar
|
|
6
|
Feitelson MA and Duan LX: Hepatitis B
virus X antigen in the pathogenesis of chronic infections and the
development of hepatocellular carcinoma. Am J Pathol.
150:1141–1157. 1997.PubMed/NCBI
|
|
7
|
Majumder M, Ghosh AK, Steele R, Ray R and
Ray RB: Hepatitis C virus NS5A physically associates with p53 and
regulates p21/waf1 gene expression in a p53-dependent manner. J
Virol. 75:1401–1407. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Boyault S, Rickman DS, de Reyniès A,
Balabaud C, Rebouissou S, Jeannot E, Hérault A, Saric J, Belghiti
J, Franco D, et al: Transcriptome classification of HCC is related
to gene alterations and to new therapeutic targets. Hepatology.
45:42–52. 2007. View Article : Google Scholar
|
|
9
|
Katoh H, Ojima H, Kokubu A, Saito S, Kondo
T, Kosuge T, Hosoda F, Imoto I, Inazawa J, Hirohashi S, et al:
Genetically distinct and clinically relevant classification of
hepatocellular carcinoma: Putative therapeutic targets.
Gastroenterology. 133:1475–1486. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mann CD, Neal CP, Garcea G, Manson MM,
Dennison AR and Berry DP: Prognostic molecular markers in
hepatocellular carcinoma: A systematic review. Eur J Cancer.
43:979–992. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sarkar D and Fisher PB: AEG-1/MTDH/LYRIC:
Clinical significance. Adv Cancer Res. 120:39–74. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yoo BK, Emdad L, Lee SG, Su ZZ,
Santhekadur P, Chen D, Gredler R, Fisher PB and Sarkar D: Astrocyte
elevated gene-1 (AEG-1): A multifunctional regulator of normal and
abnormal physiology. Pharmacol Ther. 130:1–8. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee SG, Kang DC, DeSalle R, Sarkar D and
Fisher PB: AEG-1/MTDH/LYRIC, the beginning: Initial cloning,
structure, expression profile, and regulation of expression. Adv
Cancer Res. 120:1–38. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wan L, Lu X, Yuan S, Wei Y, Guo F, Shen M,
Yuan M, Chakrabarti R, Hua Y, Smith HA, et al: MTDH-SND1
interaction is crucial for expansion and activity of
tumor-initiating cells in diverse oncogene- and carcinogen-induced
mammary tumors. Cancer Cell. 26:92–105. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ying Z, Li J and Li M: Astrocyte elevated
gene 1: Biological functions and molecular mechanism in cancer and
beyond. Cell Biosci. 1:362011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yoo BK, Emdad L, Su ZZ, Villanueva A,
Chiang DY, Mukhopadhyay ND, Mills AS, Waxman S, Fisher RA, Llovet
JM, et al: Astrocyte elevated gene-1 regulates hepatocellular
carcinoma development and progression. J Clin Invest. 119:465–477.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Su ZZ, Kang DC, Chen Y, Pekarskaya O, Chao
W, Volsky DJ and Fisher PB: Identification and cloning of human
astrocyte genes displaying elevated expression after infection with
HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid
subtraction hybridization, RaSH. Oncogene. 21:3592–3602. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Brown DM and Ruoslahti E: Metadherin, a
cell surface protein in breast tumors that mediates lung
metastasis. Cancer Cell. 5:365–374. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Britt DE, Yang DF, Yang DQ, Flanagan D,
Callanan H, Lim YP, Lin SH and Hixson DC: Identification of a novel
protein, LYRIC, localized to tight junctions of polarized
epithelial cells. Exp Cell Res. 300:134–148. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sutherland HG, Lam YW, Briers S, Lamond AI
and Bickmore WA: 3D3/lyric: A novel transmembrane protein of the
endoplasmic reticulum and nuclear envelope, which is also present
in the nucleolus. Exp Cell Res. 294:94–105. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hu G, Chong RA, Yang Q, Wei Y, Blanco MA,
Li F, Reiss M, Au JL, Haffty BG and Kang Y: MTDH activation by 8q22
genomic gain promotes chemoresistance and metastasis of
poor-prognosis breast cancer. Cancer Cell. 15:9–20. 2009.
View Article : Google Scholar :
|
|
22
|
Kang DC, Su ZZ, Sarkar D, Emdad L, Volsky
DJ and Fisher PB: Cloning and characterization of HIV-1-inducible
astrocyte elevated gene-1, AEG-1. Gene. 353:8–15. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Thirkettle HJ, Girling J, Warren AY, Mills
IG, Sahadevan K, Leung H, Hamdy F, Whitaker HC and Neal DE:
LYRIC/AEG-1 is targeted to different subcellular compartments by
ubiquitinylation and intrinsic nuclear localization signals. Clin
Cancer Res. 15:3003–3013. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sarkar D: AEG-1/MTDH/LYRIC in liver
cancer. Adv Cancer Res. 120:193–221. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li J, Zhang N, Song LB, Liao WT, Jiang LL,
Gong LY, Wu J, Yuan J, Zhang HZ, Zeng MS, et al: Astrocyte elevated
gene-1 is a novel prognostic marker for breast cancer progression
and overall patient survival. Clin Cancer Res. 14:3319–3326. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jianbo X, Hui W, Yulong H, Changhua Z,
Longjuan Z, Shirong C and Wenhua Z: Astrocyte-elevated gene-1
overexpression is associated with poor prognosis in gastric cancer.
Med Oncol. 28:455–462. 2011. View Article : Google Scholar
|
|
27
|
Sun W, Fan YZ, Xi H, Lu XS, Ye C and Zhang
JT: Astrocyte elevated gene-1 overexpression in human primary
gallbladder carcinomas: An unfavorable and independent prognostic
factor. Oncol Rep. 26:1133–1142. 2011.PubMed/NCBI
|
|
28
|
Song HT, Qin Y, Yao GD, Tian ZN, Fu SB and
Geng JS: Astrocyte elevated gene-1 mediates glycolysis and
tumorigenesis in colorectal carcinoma cells via AMPK signaling.
Mediators Inflamm. 2014:2873812014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen W, Ke Z, Shi H, Yang S and Wang L:
Overexpression of AEG-1 in renal cell carcinoma and its correlation
with tumor nuclear grade and progression. Neoplasma. 57:522–529.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yu C, Chen K, Zheng H, Guo X, Jia W, Li M,
Zeng M, Li J and Song L: Overexpression of astrocyte elevated
gene-1 (AEG-1) is associated with esophageal squamous cell
carcinoma (ESCC) progression and pathogenesis. Carcinogenesis.
30:894–901. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Song L, Li W, Zhang H, Liao W, Dai T, Yu
C, Ding X, Zhang L and Li J: Over-expression of AEG-1 significantly
associates with tumour aggressiveness and poor prognosis in human
non-small cell lung cancer. J Pathol. 219:317–326. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Huang Y, Ren GP, Xu C, Dong SF, Wang Y,
Gan Y, Zhu L and Feng TY: Expression of astrocyte elevated gene-1
(AEG-1) as a biomarker for aggressive pancreatic ductal
adenocarcinoma. BMC Cancer. 14:4792014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ke ZF, He S, Li S, Luo D, Feng C and Zhou
W: Expression characteristics of astrocyte elevated gene-1 (AEG-1)
in tongue carcinoma and its correlation with poor prognosis. Cancer
Epidemiol. 37:179–185. 2013. View Article : Google Scholar
|
|
34
|
Emdad L, Sarkar D, Lee SG, Su ZZ, Yoo BK,
Dash R, Yacoub A, Fuller CE, Shah K, Dent P, et al: Astrocyte
elevated gene-1: A novel target for human glioma therapy. Mol
Cancer Ther. 9:79–88. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Long M, Hao M, Dong K, Shen J, Wang X, Lin
F, Liu L, Wei J, Liang Y, Yang J, et al: AEG-1 overexpression is
essential for maintenance of malignant state in human AML cells via
up-regulation of Akt1 mediated by AuRKA activation. Cell Signal.
25:1438–1446. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lee SG, Jeon HY, Su ZZ, Richards JE,
Vozhilla N, Sarkar D, Van Maerken T and Fisher PB: Astrocyte
elevated gene-1 contributes to the pathogenesis of neuroblastoma.
Oncogene. 28:2476–2484. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xia Z, Zhang N, Jin H, Yu Z, Xu G and
Huang Z: Clinical significance of astrocyte elevated gene-1
expression in human oligodendrogliomas. Clin Neurol Neurosurg.
112:413–419. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang F, Ke ZF, Sun SJ, Chen WF, Yang SC,
Li SH, Mao XP and Wang LT: Oncogenic roles of astrocyte elevated
gene-1 (AEG-1) in osteosarcoma progression and prognosis. Cancer
Biol Ther. 12:539–548. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Long M, Dong K, Gao P, Wang X, Liu L, Yang
S, Lin F, Wei J and Zhang H: Overexpression of astrocyte-elevated
gene-1 is associated with cervical carcinoma progression and
angiogenesis. Oncol Rep. 30:1414–1422. 2013.PubMed/NCBI
|
|
40
|
Li C, Chen K, Cai J, Shi QT, Li Y, Li L,
Song H, Qiu H, Qin Y and Geng JS: Astrocyte elevated gene-1: A
novel independent prognostic biomarker for metastatic ovarian
tumors. Tumour Biol. 35:3079–3085. 2014. View Article : Google Scholar
|
|
41
|
He XX, Chang Y, Meng FY, Wang MY, Xie QH,
Tang F, Li PY, Song YH and Lin JS: MicroRNA-375 targets AEG-1 in
hepatocellular carcinoma and suppresses liver cancer cell growth in
vitro and in vivo. Oncogene. 31:3357–3369. 2012. View Article : Google Scholar
|
|
42
|
Zhu K, Dai Z, Pan Q, Wang Z, Yang GH, Yu
L, Ding ZB, Shi GM, Ke AW, Yang XR, et al: Metadherin promotes
hepatocellular carcinoma metastasis through induction of
epithelial-mesenchymal transition. Clin Cancer Res. 17:7294–7302.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zheng J, Li C, Wu X, Yang Y, Hao M, Sheng
S, Sun Y, Zhang H, Long J and Hu C: Astrocyte elevated gene-1 is a
novel biomarker of epithelial-mesenchymal transition and
progression of hepatocellular carcinoma in two China regions.
Tumour Biol. 35:2265–2269. 2014. View Article : Google Scholar
|
|
44
|
Gong Z, Liu W, You N, Wang T, Wang X, Lu
P, Zhao G, Yang P, Wang D and Dou K: Prognostic significance of
metadherin over-expression in hepatitis B virus-related
hepatocellular carcinoma. Oncol Rep. 27:2073–2079. 2012.PubMed/NCBI
|
|
45
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Srivastava J, Siddiq A, Gredler R, Shen
XN, Rajasekaran D, Robertson CL, Subler MA, Windle JJ, Dumur CI,
Mukhopadhyay ND, et al: Astrocyte elevated gene-1 (AEG-1) and c-Myc
cooperate to promote hepatocarcinogenesis. Hepatology. 61:915–929.
2014. View Article : Google Scholar
|
|
47
|
Deng H, Zhou Z, Tu W, Xia Y, Huang H and
Tian D: Knockdown of astrocyte elevated gene-1 inhibits growth
through suppression of IL-6 secretion in HepG2 human hepatoma
cells. Oncol Lett. 7:101–106. 2014.
|
|
48
|
Ma J, Xie SL, Geng YJ, Jin S, Wang GY and
Lv GY: In vitro regulation of hepatocellular carcinoma cell
viability, apoptosis, invasion, and AEG-1 expression by LY294002.
Clin Res Hepatol Gastroenterol. 38:73–80. 2014. View Article : Google Scholar
|
|
49
|
Srivastava J, Siddiq A, Emdad L,
Santhekadur PK, Chen D, Gredler R, Shen XN, Robertson CL, Dumur CI,
Hylemon PB, et al: Astrocyte elevated gene-1 promotes
hepatocarcinogenesis: Novel insights from a mouse model.
Hepatology. 56:1782–1791. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Tang ZY, Ye SL, Liu YK, Qin LX, Sun HC, Ye
QH, Wang L, Zhou J, Qiu SJ, Li Y, et al: A decade’s studies on
metastasis of hepato cellular carcinoma. J Cancer Res Clin Oncol.
130:187–196. 2004. View Article : Google Scholar
|
|
51
|
Peng YF, Shi YH, Ding ZB, Ke AW, Gu CY,
Hui B, Zhou J, Qiu SJ, Dai Z and Fan J: Autophagy inhibition
suppresses pulmonary metastasis of HCC in mice via impairing
anoikis resistance and colonization of HCC cells. Autophagy.
9:2056–2068. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zheng J, Li C, Wu X, Liu M, Sun X, Yang Y,
Hao M, Sheng S, Sun Y, Zhang H, et al: Huaier polysaccharides
suppresses hepatocarcinoma MHCC97-H cell metastasis via
inactivation of EMT and AEG-1 pathway. Int J Biol Macromol.
64:106–110. 2014. View Article : Google Scholar
|
|
53
|
Frisch SM and Screaton RA: Anoikis
mechanisms. Curr Opin Cell Biol. 13:555–562. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Zhou Z, Deng H, Yan W, Luo M, Tu W, Xia Y,
He J, Han P, Fu Y and Tian D: AEG-1 promotes anoikis resistance and
orientation chemotaxis in hepatocellular carcinoma cells. PLoS One.
9:e1003722014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Yoo BK, Gredler R, Vozhilla N, Su ZZ, Chen
D, Forcier T, Shah K, Saxena U, Hansen U, Fisher PB, et al:
Identification of genes conferring resistance to 5-fluorouracil.
Proc Natl Acad Sci USA. 106:12938–12943. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Yoo BK, Chen D, Su ZZ, Gredler R, Yoo J,
Shah K, Fisher PB and Sarkar D: Molecular mechanism of
chemoresistance by astrocyte elevated gene-1. Cancer Res.
70:3249–3258. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Liu H, Song X, Liu C, Xie L, Wei L and Sun
R: Knockdown of astrocyte elevated gene-1 inhibits proliferation
and enhancing chemo-sensitivity to cisplatin or doxorubicin in
neuroblastoma cells. J Exp Clin Cancer Res. 28:192009. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Min L, He B and Hui L: Mitogen-activated
protein kinases in hepatocellular carcinoma development. Semin
Cancer Biol. 21:10–20. 2011. View Article : Google Scholar
|
|
59
|
Thompson MD and Monga SP: WNT/beta-catenin
signaling in liver health and disease. Hepatology. 45:1298–1305.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Villanueva A, Chiang DY, Newell P, Peix J,
Thung S, Alsinet C, Tovar V, Roayaie S, Minguez B, Sole M, et al:
Pivotal role of mTOR signaling in hepatocellular carcinoma.
Gastroenterology. 135:1972–1983. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Pikarsky E, Porat RM, Stein I, Abramovitch
R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E and
Ben-Neriah Y: NF-kappaB functions as a tumour promoter in
inflammation-associated cancer. Nature. 431:461–466. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Lee SG, Su ZZ, Emdad L, Sarkar D and
Fisher PB: Astrocyte elevated gene-1 (AEG-1) is a target gene of
oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc.
Proc Natl Acad Sci USA. 103:17390–17395. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Wands JR and Kim M: WNT/β-catenin
signaling and hepato-cellular carcinoma. Hepatology. 60:452–454.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Tanaka S, Sugimachi K, Kameyama T, Maehara
S, Shirabe K, Shimada M, Wands JR and Maehara Y: Human WISP1v, a
member of the CCN family, is associated with invasive
cholan-giocarcinoma. Hepatology. 37:1122–1129. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Wang S, Huang X, Li Y, Lao H, Zhang Y,
Dong H, Xu W, Li JL and Li M: RN181 suppresses hepatocellular
carcinoma growth by inhibition of the ERK/MAPK pathway. Hepatology.
53:1932–1942. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Guichard C, Amaddeo G, Imbeaud S, Ladeiro
Y, Pelletier L, Maad IB, Calderaro J, Bioulac-Sage P, Letexier M,
Degos F, et al: Integrated analysis of somatic mutations and focal
copy-number changes identifies key genes and pathways in
hepatocellular carcinoma. Nat Genet. 44:694–698. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Srivastava J, Robertson CL, Rajasekaran D,
Gredler R, Siddiq A, Emdad L, Mukhopadhyay ND, Ghosh S, Hylemon PB,
Gil G, et al: AEG-1 regulates retinoid X receptor and inhibits
retinoid signaling. Cancer Res. 74:4364–4377. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Emdad L, Sarkar D, Su ZZ, Randolph A,
Boukerche H, Valerie K and Fisher PB: Activation of the nuclear
factor κB pathway by astrocyte elevated gene-1: Implications for
tumor progression and metastasis. Cancer Res. 66:1509–1516. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Sarkar D, Park ES, Emdad L, Lee SG, Su ZZ
and Fisher PB: Molecular basis of nuclear factor-κB activation by
astrocyte elevated gene-1. Cancer Res. 68:1478–1484. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Hösel M, Quasdorff M, Wiegmann K, Webb D,
Zedler U, Broxtermann M, Tedjokusumo R, Esser K, Arzberger S,
Kirschning CJ, et al: Not interferon, but interleukin-6 controls
early gene expression in hepatitis B virus infection. Hepatology.
50:1773–1782. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Tai DI, Tsai SL, Chang YH, Huang SN, Chen
TC, Chang KS and Liaw YF: Constitutive activation of nuclear factor
κB in hepato-cellular carcinoma. Cancer. 89:2274–2281. 2000.
View Article : Google Scholar
|
|
72
|
Liu P, Kimmoun E, Legrand A, Sauvanet A,
Degott C, Lardeux B and Bernuau D: Activation of NF-κB, AP-1 and
STAT transcription factors is a frequent and early event in human
hepatocellular carcinomas. J Hepatol. 37:63–71. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Robertson CL, Srivastava J, Siddiq A,
Gredler R, Emdad L, Rajasekaran D, Akiel M, Shen XN, Guo C,
Giashuddin S, et al: Genetic deletion of AEG-1 prevents
hepatocarcinogenesis. Cancer Res. 74:6184–6193. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Grabinski N, Ewald F, Hofmann BT, Staufer
K, Schumacher U, Nashan B and Jücker M: Combined targeting of AKT
and mTOR synergistically inhibits proliferation of hepatocellular
carcinoma cells. Mol Cancer. 11:852012. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Yoo BK, Emdad L, Gredler R, Fuller C,
Dumur CI, Jones KH, Jackson-Cook C, Su ZZ, Chen D, Saxena UH, et
al: Transcription factor Late SV40 Factor (LSF) functions as an
oncogene in hepatocellular carcinoma. Proc Natl Acad Sci USA.
107:8357–8362. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Santhekadur PK, Gredler R, Chen D, Siddiq
A, Shen XN, Das SK, Emdad L, Fisher PB and Sarkar D: Late SV40
factor (LSF) enhances angiogenesis by transcriptionally
up-regulating matrix metalloproteinase-9 (MMP-9). J Biol Chem.
287:3425–3432. 2012. View Article : Google Scholar :
|
|
77
|
Yoo BK, Gredler R, Chen D, Santhekadur PK,
Fisher PB and Sarkar D: c-Met activation through a novel pathway
involving osteopontin mediates oncogenesis by the transcription
factor LSF. J Hepatol. 55:1317–1324. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Chen D, Siddiq A, Emdad L, Rajasekaran D,
Gredler R, Shen XN, Santhekadur PK, Srivastava J, Robertson CL,
Dmitriev I, et al: Insulin-like growth factor-binding protein-7
(IGFBP7): A promising gene therapeutic for hepatocellular carcinoma
(HCC). Mol Ther. 21:758–766. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Chen D, Yoo BK, Santhekadur PK, Gredler R,
Bhutia SK, Das SK, Fuller C, Su ZZ, Fisher PB and Sarkar D:
Insulin-like growth factor-binding protein-7 functions as a
potential tumor suppressor in hepatocellular carcinoma. Clin Cancer
Res. 17:6693–6701. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Tomimaru Y, Eguchi H, Wada H, Kobayashi S,
Marubashi S, Tanemura M, Umeshita K, Kim T, Wakasa K, Doki Y, et
al: IGFBP7 downregulation is associated with tumor progression and
clinical outcome in hepatocellular carcinoma. Int J Cancer.
130:319–327. 2012. View Article : Google Scholar
|
|
81
|
Leverson JD, Koskinen PJ, Orrico FC,
Rainio EM, Jalkanen KJ, Dash AB, Eisenman RN and Ness SA: Pim-1
kinase and p100 cooperate to enhance c-Myb activity. Mol Cell.
2:417–425. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Wang X, Liu X, Fang J, Lu Y, He J, Yao X,
Yao Z and Yang J: Coactivator P100 protein enhances STAT6-dependent
transcriptional activation but has no effect on STAT1-mediated gene
transcription. Anat Rec. 293:1010–1016. 2010. View Article : Google Scholar
|
|
83
|
Gao X, Zhao X, Zhu Y, He J, Shao J, Su C,
Zhang Y, Zhang W, Saarikettu J, Silvennoinen O, et al: Tudor
staphylococcal nuclease (Tudor-SN) participates in small
ribonucleoprotein (snRNP) assembly via interacting with
symmetrically dimethylated Sm proteins. J Biol Chem.
287:18130–18141. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Gao X, Ge L, Shao J, Su C, Zhao H,
Saarikettu J, Yao X, Yao Z, Silvennoinen O and Yang J: Tudor-SN
interacts with and co-localizes with G3BP in stress granules under
stress conditions. FEBS Lett. 584:3525–3532. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Yoo BK, Santhekadur PK, Gredler R, Chen D,
Emdad L, Bhutia S, Pannell L, Fisher PB and Sarkar D: Increased
RNA-induced silencing complex (RISC) activity contributes to
hepatocellular carcinoma. Hepatology. 53:1538–1548. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Yin J, Ding J, Huang L, Tian X, Shi X, Zhi
L, Song J, Zhang Y, Gao X, Yao Z, et al: SND1 affects proliferation
of hepato-cellular carcinoma cell line SMMC-7721 by regulating
IGFBP3 expression. Anat Rec. 296:1568–1575. 2013. View Article : Google Scholar
|
|
87
|
Santhekadur PK, Das SK, Gredler R, Chen D,
Srivastava J, Robertson C, Baldwin AS Jr, Fisher PB and Sarkar D:
Multifunction protein staphylococcal nuclease domain containing 1
(SND1) promotes tumor angiogenesis in human hepatocellular
carcinoma through novel pathway that involves nuclear factor κB and
miR-221. J Biol Chem. 287:13952–13958. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Song H, Li C, Li R and Geng J: Prognostic
significance of AEG-1 expression in colorectal carcinoma. Int J
Colorectal Dis. 25:1201–1209. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Llovet JM, Ricci S, Mazzaferro V, Hilgard
P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A,
et al: SHARP Investigators Study Group: Sorafenib in advanced
hepatocellular carcinoma. N Engl J Med. 359:378–390. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Liang JJ, Zhou YY, Wu J and Ding Y: Gold
nanoparticle-based drug delivery platform for antineoplastic
chemotherapy. Curr Drug Metab. 15:620–631. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Dykman LA and Khlebtsov NG: Uptake of
engineered gold nanoparticles into mammalian cells. Chem Rev.
114:1258–1288. 2014. View Article : Google Scholar
|
